Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: J Thorac Oncol. 2021 May 25;16(10):1694–1704. doi: 10.1016/j.jtho.2021.05.004

Figure 4: Cell-cell interface between cancer cells and T cells is more frequent in the MHCIIhi TME.

Figure 4:

A) Representative images of cell interface analysis between cancer cells and CD8+ T cells in an MHCIIhi and MHCIIlo tumor. B) Percent of cancer cells with a cell surface interface with CD4 + or CD8 + T cells based on tumor MHC status, unpaired t-test, *p<.05, **p<.01. C) Representative images of cell interface analysis between cancer cells and CD4+ T cells in an MHCIIhi or an MHCIIlo tumor.